 | Up a level |
Putora, Paul Martin; Glatzer, Markus; De Ruysscher, Dirk; Faivre-Finn, Corinne; Belderbos, José; Besse, Benjamin; Blackhall, Fiona; Califano, Raffaele; Cappuzzo, Federico; de Marinis, Filippo; Dziadiuszko, Rafal; Felip, Enriqueta; Früh, Martin; Garrido, Pilar; Le Pechoux, Cecile; McDonald, Fiona; Nestle, Ursula; Novello, Silvia; Brien, Mary O'; Paz Ares, Luis; ... (2019). Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiotherapy and oncology, 135, pp. 74-77. Elsevier 10.1016/j.radonc.2019.02.010
Dziadziuszko, Rafal; Smit, Egbert F; Dafni, Urania; Wolf, Juergen; Wasąg, Bartosz; Biernat, Wojciech; Finn, Stephen P; Kammler, Roswitha; Tsourti, Zoi; Rabaglio, Manuela; Ruepp, Barbara; Roschitzki-Voser, Heidi; Stahel, Rolf A; Felip, Enriqueta; Peters, Solange (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). Journal of thoracic oncology, 14(6), pp. 1086-1094. Elsevier 10.1016/j.jtho.2019.02.017
Putora, Paul Martin; Glatzer, Markus; Belderbos, José; Besse, Benjamin; Blackhall, Fiona; Califano, Raffaele; Cappuzzo, Federico; de Marinis, Filippo; Dziadziuszko, Rafal; Felip, Enriqueta; Faivre-Finn, Corinne; Früh, Martin; Garrido, Pilar; Le Pechoux, Cecila; McDonald, Fiona; Nestle, Ursula; Novello, Silvia; O'Brien, Mary; Paz Ares, Luis; Peeters, Stephanie; ... (2019). Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiotherapy and oncology, 133, pp. 163-166. Elsevier 10.1016/j.radonc.2018.12.014
Peters, Solange; Gettinger, Scott; Johnson, Melissa L; Jänne, Pasi A; Garassino, Marina C; Christoph, Daniel; Toh, Chee Keong; Rizvi, Naiyer A; Chaft, Jamie E; Carcereny Costa, Enric; Patel, Jyoti D; Chow, Laura Q M; Koczywas, Marianna; Ho, Cheryl; Früh, Martin; van den Heuvel, Michel; Rothenstein, Jeffrey; Reck, Martin; Paz-Ares, Luis; Shepherd, Frances A; ... (2017). Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH). Journal of clinical oncology, 35(24), pp. 2781-2789. American Society of Clinical Oncology 10.1200/JCO.2016.71.9476
